Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery

Published:2019-03 Issue:3 Volume:157 Page:1249-1259.e5
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Barbetta Arianna,Sihag Smita,Nobel Tamar,Hsu Meier,Tan Kay See,Bains Manjit,Jones David R.,Molena Daniela

Funder

National Cancer Institute

Esophageal Cancer Education Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference23 articles.

1. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

2. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials;Liu;Oncotarget,2017

3. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis;Gebski;Lancet Oncol,2007

4. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities;Napier;World J Gastrointest Oncol,2014

5. Integrated genomic characterization of oesophageal carcinoma;Cancer Genome Atlas Research Network;Nature,2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery;Annals of Surgical Oncology;2024-07-02

2. Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma;The Annals of Thoracic Surgery;2024-07

3. The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy;European Journal of Cardio-Thoracic Surgery;2024-05-29

4. The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy;Biomedicines;2024-05-16

5. Multi-disciplinary management of esophageal carcinoma: Current practices and future directions;Critical Reviews in Oncology/Hematology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3